Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications

    Pharmacognosy Communications, Vol 7, Issue 3, Jul-Dec, 2017

    Editorial

    Editorial

    I.E.Cock1,2*1School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, Australia.2Environmental Futures Research Institute, Nathan ...
    Read More
    PICTORIAL ABSTRACT

    Investigating the Pharmacognostic Potential of Indian Terminalia Spp. in the Treatment and Prevention of Yersiniosis

    Mitchell Henry Wright,a Anthony Carlson Greene,b Ian Edwin Cock,b,c*aDivision of Environmental and Biomolecular Systems, Institute of Environmental Health, Oregon Health ...
    Read More
    Pathological and Immunohistochemical staining of Streptozotocin- induced diabetic male wistar rat pancreatic tissues Figure 5: Pathological and Immunohistochemical analysis of rat pancreas streptozotocin induced diabetic male Wistar rats were treated with MTLMAF the pancreas were isolated for anti-insulin immunostaining against insulin antibodies as visualized by the confocal microscopy equipped with an excitation filter 515-560 and magnification at 20x, scale bar: 10 μm. Gp 1- Normal rats, Gp II STZ-induced diabetic control rats, Gp III - Diabetic rats with MTLMAF (100 mg/kg), Gp IV - Diabetic rats with MTLMAF (200 mg/kg), Gp V - Control rats with only MTLMAF (1000 mg/kg), Gp VI - Diabetic rats with Standard Metformin 100 mg/kg. An Arrow mark indicates co-localization.

    Antidiabetic Effect of Memecylon Talbotianum Leaf Methanol Active Fraction in Male Wistar Rats

    Bharathi T.R., Noor Mohamed Jameel, Behrouz Jalali Ghassam, Shrisha Naik Bajpe, Prakash HS*Department of Studies in Biotechnology, University of Mysore, ...
    Read More
    PICTORIAL ABSTRACT

    Inhibition of the Growth of a Panel of Pathogenic Bacteria by Kunzea flavescens C.T. White and W.D. Francis Solvent Extractions

    Getmore Rumbudzai Chikowe,a Lindiwe Nomathemba Mpala,a Ian Edwin Cocka,b*aSchool of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, ...
    Read More
    PICTORIAL ABSTRACT

    Growth Inhibitory Activity of Selected Australian Syzygium Species against Malodour Forming Bacteria

    Aiden Joshua Wood,a Kane McManus,a Mitchell Henry Wright,b Anthony Carlson Greene,a Ian Edwin Cock,a,c,*aSchool of Natural Sciences, Griffith University, Nathan ...
    Read More
    The Janus Corner

    The Janus Corner

    Mitchell Henry Wright,* Derek Anthony Pica II Division of Environmental and Biomolecular Systems, Institute of Environmental Health, Oregon Health and ...
    Read More
    Medicinal Plant Images

    Medicinal Plant Images

    I.E. Cocka,b*aEnvironmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, Australia.bSchool of Natural Sciences, ...
    Read More
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up